CTIS.eu › Cities › Netherlands › Arnhem
Arnhem
Netherlands
165 total trials
82 recruiting
2024-516068-27-01
5
2025-04-10
cardiopulmonary resuscitation
2023-505311-20-01
5
2025-03-21
Metastatic Non-Small Cell Lung Cancer
2024-512628-12-00
10
2025-01-28
Primary aldosteronism
2024-511359-16-00
5
2025-01-17
Osteoarthritis
2023-507489-20-00
6
2024-12-10
Statin-intolerance
2024-513092-40-00
6
2024-12-05
Stroke
2024-512602-26-00
6
2024-12-02
Uterine fibroids
2024-512571-12-00
6
2024-11-29
Infertility
2023-508902-66-00
4
2024-11-28
relapsed / refractory multiple myeloma
2024-518878-14-01
6
2024-11-25
Inflammatory bowel disease
2024-514055-15-00
6
2024-11-19
Pulmonary sarcoidosis
2024-515705-26-00
4
2024-11-11
Stroke
2024-517230-17-00
4
2024-10-28
Intracerebral haemorrhage
2024-516432-94-00
6
2024-10-21
N/A
2023-509706-30-00
5
2024-10-18
Heart failure (HF)
2023-506115-17-00
5
2024-10-14
Metastatic Colorectal Cancer
2024-514620-17-00
4
2024-10-14
Patients with early-stage rectal cancer (defined as early rectal cance
2024-517783-37-00
6
2024-09-20
ST elevation myocardial infarction (STEMI)
2024-516277-68-00
6
2024-09-19
Crohn's disease
Ulcerative colitis
2024-516195-15-00
5
2024-09-10
Advanced NSCLC
2023-505377-32-00
5
2024-08-15
Diffuse large B-cell lymphoma (DLBCL)
2024-513363-15-01
11
2024-07-22
(Chronic) Peripheral (occlusive) arterial disease (PAD)
2023-508162-15-00
5
2024-07-12
Chronic HF and comorbid impairment of kidney function who had a recent
2023-507352-72-00
6
2024-05-24
Crohn's Disease
Showing 49–72 of 165 trials